Top Markets
Coin of the day
Hyundai Pharmaceutical Co., Ltd. Hyundai Pharmaceutical Co., Ltd.

Hyundai Pharmaceutical Co., Ltd.

004310
Rangering i aksjer #22073
Headquartered in Seoul, South Korea, Hyundai Pharmaceutical Co., Ltd. is an... Headquartered in Seoul, South Korea, Hyundai Pharmaceutical Co., Ltd. is an international manufacturer and distributor of a diverse portfolio that includes pharmaceutical products, health food beverages, and medical equipment. The company's extensive offerings comprise both prescription (ETC) and over-the-counter (OTC) remedies, addressing a broad spectrum of therapeutic areas. These encompass conditions related to cardiovascular health, infectious diseases, the central nervous system, pain management, respiratory ailments, dermatological issues, digestive and endocrine system disorders, gynecological health, and ophthalmic care. Additionally, their range extends to nutritional supplements, diagnostic reagents, wound healing solutions, and treatments for allergies, arthritis, and anemia, among many others. The company was founded in 1965.
Aksjekurs
$4.05
Sist synkronisert: 2026-08-21
Markedsverdi
$94.86M
Endring (1 dag)
-4.26%
Endring (1 år)
40.34%
Land
KR
Handel Hyundai Pharmaceutical Co., Ltd. (004310)

Kategori

Pris 004310 pris med markedsverdi på B
Hyundai Pharmaceutical Co., Ltd. Hyundai Pharmaceutical Co., Ltd.
004310
$4.05
Markedsverdi av Hyundai Pharmaceutical Co., Ltd.(004310)
Markedsverdi: $94.86M
Per August 2026 har Hyundai Pharmaceutical Co., Ltd. en markedsverdi på $94.86M. Dette gjør Hyundai Pharmaceutical Co., Ltd. til det 22073rd mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Hyundai Pharmaceutical Co., Ltd. fra 2000 til 2026
004310 sammenlignet med topp 5 mest populære stocks
Pris på 004310 Eiendel B Markedsverdi for B Resultater
Hyundai Pharmaceutical Co., Ltd. Hyundai Pharmaceutical Co., Ltd.
$222,241 $94.86M
$5.211T +5,493,782.86%
Hyundai Pharmaceutical Co., Ltd. Hyundai Pharmaceutical Co., Ltd.
$193,898 $94.86M
$4.547T +4,793,130.03%
Hyundai Pharmaceutical Co., Ltd. Hyundai Pharmaceutical Co., Ltd.
$177,510 $94.86M
$4.162T +4,388,028.31%
Hyundai Pharmaceutical Co., Ltd. Hyundai Pharmaceutical Co., Ltd.
$153,216 $94.86M
$3.593T +3,787,459.81%
Hyundai Pharmaceutical Co., Ltd. Hyundai Pharmaceutical Co., Ltd.
$119,102 $94.86M
$2.793T +2,944,157.99%